Selver Isik - Publications

Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study.

Journal: Annals of Saudi medicine

Published: June 07, 2026

Capecitabine-induced pneumonitis: a rare case report and literature review.

Journal: Anti-cancer drugs

Published: May 06, 2026

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 01, 2026

Oncological Perspective on Bone-Metastatic Colorectal Cancer: a Single-Centre Experience.

Journal: Journal of gastrointestinal cancer

Published: January 01, 2026

Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations.

Journal: Medicina (Kaunas, Lithuania)

Published: June 02, 2025

HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report.

Journal: Anti-cancer drugs

Published: August 08, 2024

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.

Journal: Scientific reports

Published: November 23, 2023

Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters.

Journal: Acta radiologica (Stockholm, Sweden : 1987)

Published: November 30, 2022

Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens.

Journal: Oncology letters

Published: October 25, 2022

Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma.

Journal: Nutrition and cancer

Published: April 13, 2022

Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment.

Journal: Annals of nuclear medicine

Published: March 31, 2022

Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.

Journal: Orthopaedics & traumatology, surgery & research : OTSR

Published: February 04, 2022